T cell receptor and cytokine signaling can function at different stages to establish and maintain transcriptional memory and enable T helper cell differentiation by Bevington, Sarah L et al.
 
 
T Cell Receptor and Cytokine Signaling Can
Function at Different Stages to Establish and
Maintain Transcriptional Memory and Enable T
Helper Cell Differentiation
Bevington, Sarah; Cauchy, Pierre; Withers, David; Lane, Peter; Cockerill, Peter
DOI:
10.3389/fimmu.2017.00204
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Bevington, SL, Cauchy, P, Withers, DR, Lane, PJL & Cockerill, PN 2017, 'T Cell Receptor and Cytokine
Signaling Can Function at Different Stages to Establish and Maintain Transcriptional Memory and Enable T
Helper Cell Differentiation', Frontiers in immunology, vol. 8, 204. https://doi.org/10.3389/fimmu.2017.00204
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
March 2017 | Volume 8 | Article 2041
Review
published: 03 March 2017
doi: 10.3389/fimmu.2017.00204
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Benjamin Youngblood, 
St. Jude Children’s Research 
Hospital, USA
Reviewed by: 
Ken Oestreich, 
Virginia Tech Carilion Research 
Institute, USA  
David Hildeman, 
Cincinnati Children’s Hospital, USA
*Correspondence:
Peter N. Cockerill 
p.n.cockerill@bham.ac.uk
Specialty section: 
This article was submitted to 
Immunological Memory, 
a section of the journal 
Frontiers in Immunology
Received: 07 December 2016
Accepted: 14 February 2017
Published: 03 March 2017
Citation: 
Bevington SL, Cauchy P, Withers DR, 
Lane PJL and Cockerill PN (2017) T 
Cell Receptor and Cytokine Signaling 
Can Function at Different Stages to 
Establish and Maintain Transcriptional 
Memory and Enable 
T Helper Cell Differentiation. 
Front. Immunol. 8:204. 
doi: 10.3389/fimmu.2017.00204
T Cell Receptor and Cytokine 
Signaling Can Function at Different 
Stages to establish and Maintain 
Transcriptional Memory and enable  
T Helper Cell Differentiation
Sarah L. Bevington1, Pierre Cauchy1, David R. Withers2, Peter J. L. Lane2 and  
Peter N. Cockerill1*
1 Institute of Cancer and Genomic Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham, UK, 
2 Institute of Immunology and Immunotherapy, Institute of Biomedical Research, University of Birmingham, Birmingham, UK
Experienced T cells exhibit immunological memory via a rapid recall response, respond-
ing to restimulation much faster than naïve T cells. The formation of immunological 
memory starts during an initial slow response, when naïve T cells become transformed 
to proliferating T blast cells, and inducible immune response genes are reprogrammed 
as active chromatin domains. We demonstrated that these active domains are sup-
ported by thousands of priming elements which cooperate with inducible transcriptional 
enhancers to enable efficient responses to stimuli. At the conclusion of this response, 
a small proportion of these cells return to the quiescent state as long-term memory 
T cells. We proposed that priming elements can be established in a hit-and-run pro-
cess dependent on the inducible factor AP-1, but then maintained by the constitutive 
factors RUNX1 and ETS-1. This priming mechanism may also function to render genes 
receptive to additional differentiation-inducing factors such as GATA3 and TBX21 that 
are encountered under polarizing conditions. The proliferation of recently activated 
T cells and the maintenance of immunological memory in quiescent memory T cells are 
also dependent on various cytokine signaling pathways upstream of AP-1. We suggest 
that immunological memory is established by T cell receptor signaling, but maintained 
by cytokine signaling.
Keywords: chromatin, enhancer, epigenetics, gene regulation, immunological memory, T cells, transcription
iNTRODUCTiON
The adaptive immune system relies on both specific antigen (Ag) recognition and on the ability of 
lymphocytes to maintain a memory of previous encounters with Ags. These two features represent 
the essential basis of acquired immunity. The capacity of the immune system to recognize bil-
lions of epitopes is established via the complex process of Ag receptor gene recombination that 
produces countless combinations of specificities for foreign Ags. The ability of T cells to respond 
faster and more efficiently to weaker stimuli is supported by memory T cells which exhibit what 
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is referred to as a rapid recall response (1–10). What was until 
recently not so well defined are the molecular mechanisms that 
actually allow memory T cells to respond much more rapidly 
to re-exposure to the same Ags. Recent studies have now shown 
that the acquisition of T cell-dependent memory is supported by 
the epigenetic reprogramming of the genome via T cell receptor 
(TCR) signaling. Activation of the TCR triggers a hit-and-run 
mechanism whereby a single cycle of activation leads to the 
acquisition of thousands of stably maintained active chromatin 
regions which include many of the inducible immune response 
genes that deliver effective immune responses (10). Active 
chromatin priming is now known to be one of several parallel 
mechanisms employed by activated T cells and memory T cells 
to enable the rapid expression of immune response factors. 
It is also established that activated T cells induce cytokine or 
chemokine production by virtue of enhanced TCR signaling 
(11, 12), loss of repressive chromatin modifications (13–15), 
increased mRNA stability (16), and more efficient translation 
of cytokine mRNAs (17). However, some of these mechanisms 
are only relevant for a subset of immune response genes (18), 
whereas active chromatin modifications represent a more 
universal mechanism of maintaining immunological memory 
throughout the T cell compartment (10). In this review, we will 
focus on just the role of active chromatin priming in T cells 
and present some new analyses of previously published data to 
illustrate the potential of TCR-inducible chromatin priming in 
underpinning the subsequent stages of T cell differentiation.
T CeLL ACTivATiON AND 
DiFFeReNTiATiON
Mature T cells exit the thymus with all the genetic components 
needed to recognize Ags. However, what these naïve T cells lack 
is the ability to respond rapidly to their first encounter with 
the Ags recognized by their specific TCRs. During a produc-
tive immune response, when naïve T cells are first activated, 
they require correct Ag presentation over an extended period 
of time (~1 to 2  days) as they undergo the complex process 
of blast cell transformation. During this process they convert 
from small quiescent cells to larger highly proliferative cells 
(Figure  1A). Depending upon the nature of the Ag and the 
cytokine milieu in the environment where they reside, recently 
activated T cells can undergo further differentiation steps giving 
rise to different sub-types of effector T cells, expressing different 
combinations of immune response genes (19–22). For example, 
under the influence of IL-12 and STAT4, naïve CD4 cells tend 
to differentiate into type 1 helper (Th1) cells which can express 
inducible genes such as IFNG and GZMB which are activated 
via cooperation between the transcription factor (TF) TBX21 
(T-Bet) and TCR-inducible TFs (Figure  1A). Conversely, IL-4 
and STAT6 signaling in CD4 T cells triggers differentiation into 
type 2 helper (Th2) cells expressing TCR-inducible genes such as 
IL4 which are activated by the TF GATA3. Recently activated T 
blast cells and differentiated T cells remain tightly regulated and 
rely on ongoing activation of TCR signaling to express inducible 
immune response genes (18).
THe BASiS OF THe RAPiD ReCALL 
iMMUNOLOGiCAL ReSPONSe iN 
MeMORY T CeLLS
Once an immune response has been resolved, the vast majority of 
activated T cells die. However, a small proportion of cells return 
to the quiescent state as Ag-specific memory T cells. Unlike naïve 
T cells, memory T cells are primed and ready to respond to any 
new encounter with the same Ag. Indeed, a defining feature 
that memory T cells share with recently activated T blast cells is 
that they are capable of responding to TCR signaling to activate 
hundreds of immune response genes within 1–2 h (Figure 1B), 
whereas naïve T cells typically take about 24 h to mount a full 
response (Figure 1C) (10). The process of T blast cell transforma-
tion, which is required to make the rapid recall response possible, 
involves extensive chromatin remodeling, whereby the Brg1 SWI/
SNF family chromatin remodeling complex mediates epigenetic 
reprogramming of the genome to prime inducible loci for tran-
scriptional reactivation (24). This hit-and-run mechanism, trig-
gered by TCR signaling, establishes thousands of open chromatin 
regions embedded within extensive active chromatin domains 
(10, 18). Once formed, these primed regions are stably main-
tained by mechanisms independent of TCR signaling. Indeed, 
hit-and-run mechanisms of chromatin priming are widely used 
in eukaryotes from plants to animals to maintain transcriptional 
memory (25–29). An example of this is found in previously acti-
vated macrophages which maintain regions marked by histone 
methylation in the vicinity of inducible enhancers (30).
DeFiNiNG THe ePiGeNeTiC LANDSCAPe 
iN T CeLLS
Studies of chromatin architecture and analyses of TF binding 
within chromatin have always played a major role in studies of 
gene regulation and genome function (31–37). These studies have 
collectively shown that active gene promoters and transcriptional 
enhancers typically exist as accessible nucleosome-free regions 
known as DNase I hypersensitive sites (DHSs) (31, 37). When 
active, these open regions are also normally flanked by nucle-
osomes carrying activating chromatin modifications such as 
acetylation and methylation of specific lysines in the histone 
tails (36–39). Active enhancer elements are typically associated 
with mono- and di-methylation of lysine 4 and acetylation of 
lysine 27 in the histone H3 tail (H3K4me1/2 and H3K27ac) 
(37, 39). Analyses of epigenetic mechanisms are now routinely 
done globally, and high-throughput sequencing technologies 
make it straightforward to perform complex integrated chro-
matin and gene regulation analyses on a genome-wide basis. 
By sequencing small DNA fragments released from DHSs by 
DNase I (DNase-Seq) or transposase (ATAC-Seq) (40), and DNA 
fragments cross-linked to immunoprecipitated TFs or modified 
histones (ChIP-Seq) (Figure 2) it is possible to define complex 
gene regulation networks (41).
Previous studies in a multitude of model systems have 
reported that gene loci can be activated in a step-wise manner 
whereby DHSs are acquired in a defined sequence as cells follow 
FiGURe 2 | The basis of epigenetic profiling of DNase i hypersensitive 
sites (DHSs) by DNase-Seq and ChiP-Seq. Active gene regulatory 
elements that exist as open chromatin regions can be identified in a 
genome-wide manner by DNA sequencing of either (1) DNA fragments 
immunoprecipitated by specific antibodies from sonicated cross-linked 
chromatin (ChIP-Seq) or (2) small DNA fragments released from DHSs by 
brief digestion of chromatin with DNase I (DNase-Seq).
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FiGURe 1 | T cell activation pathways linked to immunological priming. (A) Naïve T cells are transformed by T cell receptor (TCR) signaling, leading to 
cytokine-dependent proliferation and differentiation, before reverting to quiescent memory T cells. (B,C) Quantitative PCR analyses of CSF2 mRNA expression 
relative to B2M mRNA expression in T cell subsets derived from CSF2 transgenic mice (23). Previously activated CD4 blast cells and memory T cells rapidly induce 
CSF2 mRNA when TCR signaling pathways are activated by PMA and calcium ionophore (B) (10). (C) Naïve CD4 T cells are very slow to respond to activation of 
TCR signaling by concanavalin A (10).
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a specific differentiation pathway. Interestingly, this leads to the 
acquisition of some DHSs which are associated with genes that 
exist in a transcriptionally competent but inactive state. Examples 
of DHSs that are acquired through differentiation are observed 
when CD4 T cells are polarized to alternate fates as Th1 and Th2 
cells. Hence, Th1-specific DHSs are associated with binding of 
TBX21 at the Th1 gene IFNG, and Th2-specific DHSs associated 
with GATA3 binding at the Th2 gene IL4 (42). The DHSs in these 
cells are also associated with STAT proteins in a cell type-specific 
manner. STAT4 and STAT6 binding is observed at the DHSs in 
Th1 and Th2 cells, respectively (43, 44). However, in addition to 
differentiation-specific DHSs, CD4 T cells acquire many DHSs 
in genes such as IL4 in recently activated T cells prior to terminal 
differentiation (10, 42). These newly acquired DHSs represent the 
early stages of acquiring transcriptional competency prior to the 
activation of active transcription (18, 23, 45).
It is also well established that extensive histone methylation 
and acetylation exists at genes poised for reactivation in T cells 
(8, 9, 46–48). Some genes in T cells exist in a poised state main-
tained by H3K4 di- or tri-methylation which is established by 
trithorax family SET domain proteins (28, 49, 50). In memory 
T cells, a proportion of immune response genes have their 
promoters marked by H3K4me3, whereas these genes are associ-
ated with repressive H3K27me3 modifications introduced by 
polycomb group complexes in naïve T cells (13, 46, 51–56). Both 
CD4 and CD8 memory T cells retain extensive histone acetyla-
tion and low levels of DNA methylation at immune response 
genes (48, 57–63). This is in contrast to the higher levels of DNA 
methylation observed in naïve T cells (14, 15, 42, 58, 61, 64). 
These epigenetic differences between naïve and memory 
T cells suggest that in memory T cells, immune response genes 
are maintained in a primed conformation. However, it was not 
always clear how these various chromatin states were targeted to 
specific loci at the various stages or how they were maintained. 
With the exception of the loss of DNA methylation, which 
4Bevington et al. Chromatin Priming Maintains Immunological Memory
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 204
represents a logical target for hit-and-run mechanisms of locus 
activation, active chromatin states typically rely on the continued 
presence of specific activating TFs. In the case of memory T cells, 
the specific factors responsible for maintaining chromatin prim-
ing were until recently poorly defined.
GLOBAL ANALYSiS OF CHROMATiN 
PRiMiNG iN PReviOUSLY ACTivATeD  
T CeLLS
To gain a greater understanding of epigenetic priming in T cells, we 
recently embarked on an in depth study of the chromatin modifi-
cations are first acquired occur during T blast cell transformation 
and are then maintained in differentiated T cells and memory T 
cells (10). By identifying all of the DHSs that are present in recently 
activated murine CD4 T blast cells and CD4 memory T cells, but 
not in naïve CD4 T cells, we identified ~3,000 newly acquired and 
stably maintained primed DHSs (pDHSs) that could potentially 
account for immunological memory in T cells (Figures  3A,B) 
(10). These DHSs fulfilled some of the essential features needed 
for a priming mechanism, because they supported the mainte-
nance of domains of active chromatin modified by H3K4me2 and 
H3K27ac without having any significant impact on steady-state 
levels of transcription (10, 18) (Figure 3B). Consistent with this, 
transcriptional memory has been associated with a retention of 
H3K4me2 in other systems (27, 65).
Significantly, the primed active domains seen in T cells often 
encompassed inducible DHSs (iDHSs) which are known to func-
tion in the TCR-dependent activation of immune response genes. 
The inducible enhancers associated with these pDHSs included 
those which regulate genes encoding the inducible cytokines 
IL-3, GM-CSF (CSF2), IL-13, and IL-4 (10, 23, 66–68). These 
enhancers are included in a population of several thousand highly 
iDHSs, which are closely associated with inducible genes in 
recently activated T blast cells (Figure 3C). The inducible nature 
of these loci is depicted here as a heat map showing the relative 
change in mRNA for the nearest gene to each iDHS following 
stimulation.
Somewhat paradoxically, pDHSs and iDHSs generally recruit 
the same classes of TFs, but in different proportions (Figure 3D). 
However, this makes perfect sense given that there is no substan-
tial change in the TF repertoire immediately following T blast 
cell transformation, but only later in the differentiation process 
(Figure 1A). The iDHSs are highly enriched with binding sites 
for the TCR-inducible TFs NFAT and AP-1 (Figures  3C,D), 
as well as motifs for EGR and NF-kB family TFs which can be 
induced via multiple signaling pathways (10). More than half 
of these NFAT and AP-1 motifs exist as composite NFAT/AP-1 
motifs, which are known to support cooperative binding of NFAT 
and AP-1, as previously described for the IL-2 promoter and 
the GM-CSF enhancer (69, 70). When aligned with the iDHSs, 
the AP-1 and AP-1/NFAT motifs are heavily concentrated in the 
inducible population, and they recruit the AP-1 protein JUNB 
upon stimulation (Figure 3C). By contrast, the pDHSs encom-
pass far fewer AP-1 motifs (Figure 3D), but nevertheless they still 
contain significantly more AP-1 sites than the other constitutive 
DHSs shared with naïve T cells (Figure  3A). Importantly, the 
AP-1 motifs in pDHSs can recruit the AP-1 TF JUNB, but only 
in response to stimulation (Figure 3A). The pDHSs are princi-
pally defined by the high density of RUNX1 and ETS-1 motifs, 
whereas they have a much lower density of inducible binding 
sites. Although they lack NFAT sites, subsets of these elements 
retain the ability to respond to various signaling pathways as 
they include motifs for STAT, AP-1, and IRF family TFs, and for 
the STAT6-inducible TF GATA3 (Figure  3D). The iDHSs also 
respond by recruiting constitutive TFs such as RUNX, but unlike 
the pDHSs, they lose binding of RUNX1 once the inducible fac-
tors have gone.
STUDieS OF THe Th2 CYTOKiNe GeNe 
LOCUS AS A MODeL FOR CHROMATiN 
PRiMiNG
The Th2 cytokine gene cluster encompassing Il4, Il13, and Il5 
(Figure 4) represents an ideal model for depicting the key features 
of the pDHSs and iDHSs at the different stages of T cell activation, 
expansion, and differentiation illustrated above in Figure  1A. 
These genes reside within a 145 kb chromatin domain demarcated 
by two prominent binding sites for the insulator factor CTCF 
which may represent chromatin boundaries, as previously shown 
for a cluster of CTCF sites in the IL3/CSF2 locus (71). The Th2 
cytokine gene locus is controlled by a single locus control region 
(LCR) which resides within the Rad50 gene between Il13 and Il5 
(72, 73). Significantly, with the exception of the Rad50 promoter, 
this entire 145 kb chromatin domain exists in an inaccessible and 
unmodified state in naïve T cells, as measured by DNase-Seq and 
H3K4me2 and H3K27ac ChIP-Seq (Figure 4). By contrast, the 
Irf1 chromatin domain downstream of the 3′ CTCF site is packed 
with constitutive DHSs in both naïve T cells and T blast cells.
After a cycle of TCR activation and blast cell transformation, 
actively dividing T blast cells cultured in IL-2 have acquired and 
stably maintain many additional DHSs within the Th2 cytokine 
gene locus. These pDHSs persist in non-dividing CD4 memory T 
cells and are also observed in CD8 T blast cells (Figure 4) and Th2 
T cells (75). Because the vast majority of the ~3,000 CD4 T cell 
pDHSs were also detected in CD8 T blast cells, it is likely that the 
mechanism of chromatin priming seen here is a universal feature 
of T lineage cells (10). The significance of the presence of the 
pDHSs becomes obvious once it is recognized that the pDHSs are 
embedded within extensive active chromatin domains carrying 
the activating H3K4me2 and H3K27ac modifications (Figure 4). 
Furthermore, these active domains encompass several iDHSs 
which are known to function as transcriptional enhancers (68). 
The inference here is that the pDHSs are functioning to render 
the adjacent enhancers more accessible, and therefore more 
responsive to TCR signaling. This is exemplified by the rapid 
recruitment of the AP-1 family TF JUNB in stimulated T-blast 
cells to iDHSs (Figures 3C and 4). By contrast, these enhancers 
fail to form iDHSs in stimulated naïve CD4 T cells and thymocytes 
(Figure 4), even though the AP-1 and NFAT mRNAs required for 
enhancer activation are efficiently expressed by activated naïve T 
cells (10, 23, 45).
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FiGURe 4 | Profiling of epigenetic modifications in the mouse type 2 helper cytokine gene cluster by DHS-Seq and ChiP-Seq. Profiles are based on 
published data from naïve, blast, and memory T cells (10) and include published data for CTCF ChIP-Seq from splenocytes (74).
FiGURe 3 | Continued 
identification of distinct subsets of primed DHSs (pDHSs) and inducible DHSs (iDHSs) in mouse T cells by DNase-Seq and ChiP-Seq. (A) Genome-
wide profiling of pDHSs enriched in CD4+ T blast cells relative to naïve T cells (10). Profiles are shown for the ~17,000 strongest DNase I hypersensitive sites (DHSs) 
present in naïve and/or T blast cells, centered on a 2 kb window and ranked in order of increasing intensity in T blast cells. Shown alongside are the positions of 
predicted binding motifs for AP-1, and data from parallel JUNB ChIP-Seq analyses of AP-1 binding for the same DHSs in T blast cells before and after stimulation 
with PMA and calcium ionophore. (B) Genome-wide profiling of pDHSs enriched in CD4+ memory T cells relative to naïve T cells (10). Profiles are shown for all 
DHSs centered on a 2 kb window and ranked in order of increasing intensity in memory T cells. Shown alongside is a heat map depicting the fold change in mRNA 
expression of the genes nearest to these DHSs following stimulation with PMA and calcium ionophore. (C) Genome-wide profiling of iDHSs enriched in stimulated 
CD4+ T blast cells relative to unstimulated cells (10). Profiles are shown for all DHSs centered on a 2-kb window and ranked in order of increasing intensity in 
stimulated T blast cells. Shown alongside are the positions of predicted AP-1 and composite NFAT/AP-1 binding motifs, and data from parallel JUNB ChIP-Seq 
analyses of AP-1 binding for the same DHSs in T blast cells before and after stimulation with PMA and calcium ionophore, plus a heat map depicting the fold 
change in mRNA expression of the genes nearest to these DHSs following stimulation. (D) HOMER analysis of transcription factor-binding motifs enriched in either 
pDHSs or iDHSs (10).
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STUDieS OF THe HUMAN IL3/CSF2 
LOCUS AS A MODeL FOR CHROMATiN 
PRiMiNG
Alongside the IL2 and Th2 cytokine gene loci, the human 
IL3/CSF2 locus is one of the best studied models of inducible 
cytokine gene regulation in T cells. The use of transgenic mouse 
models in parallel with human and mouse cells has made it pos-
sible to investigate the developmental regulation, the inducible 
regulation, and the conservation of regulatory elements at this 
locus (10, 23, 45, 71, 76–79). Analyses comparing thymocytes, 
spleen T cells, and T blast cells were central to the original 
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identification of DNA priming elements associated with locus 
priming and transcriptional competency in T cells (23). Similar 
to the Th2 cytokine locus, the human IL3/CSF2 locus exists as a 
tract of greater than 100 kb of unmodified inactive chromatin in 
naïve T cells, and it acquires several pDHSs and active chromatin 
domains during T blast cell transformation. Following blast cell 
transformation, several iDHSs which function as promoters and 
enhancers can then be induced within the region (10). Consistent 
with what we observed at the human locus, the mouse Il3/Csf2 
locus showed conservation of most of the pDHSs and iDHSs, 
and in this case the inactive chromatin domain spanned at least 
220  kb in naïve mouse CD4 T cells (10). Parallel functional 
analyses of pDHSs in the IL3/CSF2 locus revealed that, as a 
general rule, pDHSs, unlike iDHSs, tend not to function directly 
as transcriptional enhancers but as DNA elements that may be 
required to maintain zones of activating histone methylation and 
acetylation (23, 45). Along with similar observations made by 
others, the body of evidence now indicates that the mere pres-
ence of active chromatin modifications at DHSs is not in itself 
sufficient to predict enhancer function (80), even though this 
remains a popular assumption.
The above studies also suggested that, once established in 
response to TCR activation, pDHSs were stably maintained in 
actively dividing T cells in the presence of IL-2, and were tempo-
rally stable in circulating human T cells for what must be assumed 
to be decades (10, 23). What remains to be seen is whether ETS 
and RUNX TFs remain bound to chromatin during mitosis, as 
seen for GATA1 which functions as a mitotic bookmarking factor 
in erythroid lineage cells (81).
We confirmed that pDHSs can indeed cooperate functionally 
with inducible enhancers by deleting the human IL3 −34  kb 
pDHS from its natural context in Jurkat T cells. This deletion 
led to a marked decrease in chromatin accessibility at the nearby 
−37 kb IL3 enhancer, in parallel with a change in kinetics of IL3 
mRNA induction from a pattern resembling that seen in memory 
T cells (as in Figure 1B) to a pattern resembling that seen in naïve 
T cells (as in Figure 1C) (10). From these studies, it was apparent 
that pDHSs did indeed function locally at the level of chromatin 
accessibility, and globally there was a trend for pDHSs to reside 
within 25  kb of iDHSs at inducible loci (10). The most highly 
inducible genes were also found to be the loci where pDHSs and 
iDHSs were the closest, independently of their distance from the 
inducible promoters that they controlled.
A HiT-AND-RUN MODeL OF 
iMMUNOLOGiCAL MeMORY iN T CeLLS
Taken together, these observations support a hit-and-run model 
for the initial establishment of epigenetic priming during T blast 
cell transformation which is predicted to alter chromatin acces-
sibility (10) (Figure  5). Within the nucleus, most chromatin 
is thought to be compacted into condensed structures ~110 
to 170  nm in diameter (82), which is roughly fivefold greater 
than the classical 30 nm diameter solenoidal structure depicted 
at the bottom of Figure  5. Many immune response genes lie 
within large tracts of unmodified and inaccessible chromatin 
in thymocytes and naïve T cells, and this is likely to present a 
formidable barrier to inducible TF binding. Therefore, although 
ETS-1 and RUNX1 are already bound to the constitutive DHSs 
shared by naïve T cells and T blast cells (10), we believe that 
the chromatin harboring pDHSs is simply inaccessible to these 
TFs in naïve T cells. It is only after an extended period of TCR 
signaling and Brg1-dependent chromatin remodeling that the 
combined actions of AP-1, ETS-1, and RUNX1 are sufficient 
to open up pDHSs and modify the surrounding chromatin. 
This process of de novo DHS creation will also be considerably 
enhanced by the actions of NFAT and AP-1 at the adjacent 
enhancers during blast cell transformation. These factors are 
thought to be powerful drivers of chromatin opening and 
remodeling (24, 78). Once activated, the pDHSs are presumably 
maintained due to the high density of constitutive TF-binding 
sites, and consequently the surrounding chromatin is continu-
ously remodeled and rendered more accessible. This more active 
chromatin structure may enable the primed immune response 
genes to more rapidly re-engage AP-1 and other inducible fac-
tors at both pDHSs and iDHSs when the cells are re-challenged. 
Furthermore, the presence of extensive histone acetylation and 
methylation is likely to make these chromatin domains even 
more accessible and the nucleosomes more mobile. This view 
is supported by the fact that the iDHS at the GM-CSF enhancer 
is strongly induced in just 20 min in T blast cells (78), but this 
and many other iDHSs remain undetectable even after 4 h of 
stimulation in naïve T cells and thymocytes (10, 23, 45). The 
binding of RUNX1 to the GM-CSF enhancer (83), and other 
iDHSs (10), is also controlled at the level of chromatin acces-
sibility, because RUNX1 binding is only observed after the 
DHS has been induced. Because pDHSs exist in both CD4 and 
CD8 T blast cells, the hit-and-run epigenetic priming model 
presented in Figure 5, and exemplified in Figure 4, is likely to 
be a universal component of immunological memory in T line-
age cells. Another important feature of this model of chromatin 
priming is that pDHSs allow genes to remain in a poised state 
with essentially no change in steady-state levels of transcrip-
tion of primed loci in primed cells as compared to naïve T cells 
(10, 18). An analysis of the IL3/CSF2 locus also found that pDHSs 
do not recruit RNA Pol II or generate non-coding transcripts in 
the absence of stimulation (23).
THe ROLe OF CHROMATiN PRiMiNG iN 
SUPPORTiNG T CeLL DiFFeReNTiATiON
We find that many immune response genes, such as CSF2 and 
IL3, reach their full potential for transcriptional activation 
during the initial blast cell transformation, showing little differ-
ence in inducible mRNA expression between undifferentiated 
T blast cells and Th1 or Th2 cells, or between CD4 and CD8 
T blast cells (23). However, other genes, such as IL4 and IFNγ, are 
primed during blast cell transformation but are only expressed 
at peak levels following further differentiation in the presence of 
polarizing cytokines, as depicted in Figure 1A. For the purpose 
of this review, we performed additional analyses of public data 
sets with a view to identifying other functions for pDHSs at 
FiGURe 5 | Chromatin priming in T cells supports a rapid recall response. This model represents a closed chromatin domain, resembling that seen in 
Figure 4, which undergoes epigenetic priming in T blast cells to maintain an accessible active chromatin structure. The primed domain, but not the closed domain, 
allows for rapid recruitment of inducible factors. The primed DHSs are formed via a hit-and-run mechanism whereby inducible transcription factors (TFs) are required 
for the initial induction but not the stable maintenance of these DNase I hypersensitive sites (DHSs). By contrast, the inducible DHSs found at inducible enhancers 
form transient DHSs that are unstable in the absence of inducible TFs.
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later stages of T cell differentiation. We observed that subsets 
of the pDHSs that are formed during blast cell transformation 
are predicted to subsequently play additional roles in support-
ing the gene regulation networks that are established by newly 
induced master regulator TFs under polarizing cytokine gene 
conditions, as depicted in Figure  6A. Although pDHSs arise 
prior to helper T cell differentiation, some of these pDHSs, such 
as those seen in the Th2 cytokine gene locus, encompass GATA 
motifs (Figure 3D). For example, the Rad50 +52 kb DHS in the 
Th2 LCR encompasses three GATA motifs (10), and many of 
the pDHSs in this locus recruit GATA3 after Th2 differentiation 
(Figure 7A).
To investigate the role of pDHSs in Th differentiation on a more 
global scale, we looked for the overlap between the 2,882 pDHSs 
that we defined in CD4 T blasts cells and the previously defined 
ChIP-Seq peaks taken from published studies of (i) GATA3 in 
Th2 cells, (ii) TBX21 in Th1 cells, and (iii) RORγ in Th17 cells 
(Figures 6B,C). Significantly, we found that 23% of the pDHSs 
were capable of recruiting TBX21, and 42% of the pDHSs were 
capable of recruiting GATA3 following differentiation.
AB
C
FiGURe 6 | Chromatin priming in undifferentiated CD4 T cells creates open chromatin at regions encompassing binding sites for differentiation-
inducing transcription factors. (A) Schematic of differentiation pathways leading to type 1 helper (Th1), type 2 helper (Th2), and Th17 cells. (B) Venn diagrams 
showing overlaps of previously defined ChIP-Seq peaks for GATA3 in Th2 cells (84) (left) and for TBX21 (T-Bet) in Th1 cells (85) (right) with the 2,882 primed DHSs 
(pDHSs) previously defined in CD4 T cells (10) as depicted in Figure 3. (C) Venn diagram depicting the overlap of Th2 GATA3, Th1 TBX21, and Th17 RORγ (86) 
ChIP-Seq peaks intersecting with the 2,882 pDHSs, with examples of corresponding gene expression patterns previously defined in Th1 (87), Th2 (88), and Th17 
(87) cells for representative genes that are associated with pDHSs.
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C
FiGURe 7 | Continued
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FiGURe 7 | Continued 
Chromatin profiling of genes which are primed during blast cell transformation for subsequent binding of differentiation-inducing transcription 
factors. Shown here are the previously defined profiles for the mouse type 2 helper (Th2) cytokine gene cluster (A), the Ccl1 locus (B), and the Il12rb2/Il23r locus 
(C), showing epigenetic profiles defined by Bevington et al. (10), plus other profiles for type 1 helper (Th1) DNase-Seq (89) and TBX21 ChIP-Seq (85), Th2 ATAC-Seq 
(90) and GATA3 ChIP-Seq (84), and Th17 RORγ ChIP-Seq (86). Note that ATAC-Seq is an alternative method for genome-wide profiling of DNase I hypersensitive 
sites (DHSs).
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To compare the relationship between pDHSs and the polarized 
mRNA expression patterns in differentiated cells (Figure 6A), we 
also compared the above ChIP-Seq and pDHS data with published 
mRNA data for the same cell types (Figure 6C). This allowed us 
to identify clear examples where elevated mRNA profiles were 
matched by recruitment of polarizing TFs to pDHSs. Hence, 
pDHSs recruit GATA3 to Il4 and Ccl1 in Th2 cells, TBX21 to 
Gzmb in Th1 cells, and RORγ to IL23r and Il17ra in Th17 cells. 
Interestingly, Th1 cells are closely related to Th17 cells, and we 
see a distinct overlap in the pDHS and ChIP-Seq profiles at genes 
such as Ifgr1 and Il12rb2 which are upregulated in both Th1 and 
Th17 cells (Figure 6C). Additional examples of specific pDHSs 
associated with locus polarization can be seen in Figure 7B where 
GATA3 is recruited to pDHSs within the Ccl1 locus in Th2 cells, 
and in Figure  7C where TBX21 and/or RORγ are recruited to 
pDHSs within the Il12rb2/Il23r locus following Th1 or Th17 
differentiation.
THe ReQUiReMeNT FOR CYTOKiNe 
SiGNALiNG TO ReiNFORCe 
iMMUNOLOGiCAL MeMORY
Despite the apparently stable nature of priming at pDHSs, it 
is well established that the maintenance of acquired immunity 
is itself highly dependent upon continual reinforcement from 
various cytokine and TNF receptor super family (TNFRSF) 
signaling networks (91–94). The requirement for gamma chain 
cytokines, particularly interleukin 7 (IL-7), for the survival of 
naïve and memory T cells is well documented (95, 96). Memory 
CD4 T cells were initially divided into two subsets based on 
their expression of molecules enabling recirculation through 
lymph nodes (a CCR7 and CD62L-dependent process) and their 
cytokine profile after restimulation (97, 98). The term “central 
memory” described those CD4 T cells that expressed CCR7 and 
so could traffic through lymph nodes, but produced mostly IL-2 
in the absence of effector cytokines; “effector memory” defined 
those cells lacking expression of CCR7, but able to rapidly pro-
duce effector cytokines such as IFNγ upon restimulation (97, 
98). Thus memory CD4 T cell populations appear to divide the 
labor of surveying the periphery for signs of re-infection, while 
also being positioned to re-expand T cell populations within 
secondary lymphoid tissue and support other adaptive immune 
cells. More recently, analysis of endogenous Ag-specific memory 
CD4 T cells generated in a systemic Th1 response has provided 
data consistent with this nomenclature. Tracking 2W1S-specific 
responses induced by attenuated Listeria monocytogenes, the 
CCR7−CXCR5− memory population rapidly produced IFNγ 
and IL-2, but only gave rise to more effector memory cells, while 
the CCR7+CXCR5+ cells generated mostly IL-2 but could gen-
erate both effector and follicular CD4 T cell subsets (99). There 
is evidence that Th1 effector memory cells are dependent on 
signaling through the TNF receptor super family protein OX40 
(TNFRSF4) (100, 101). Furthermore, an OX40-deficient human 
has been described (91), who had no in vitro detectable recall 
responses, while nevertheless clearly being able to control most 
infections. Strikingly, despite being vaccinated three times with 
live attenuated BCG vaccine, no detectable in  vitro or in  vivo 
responses were detected, although the patient did not succumb 
to BCG disease. This phenotype of failing to mount rapid recall 
responses indicates a lack of, or impairment within the effec-
tor memory cell compartment. Mice in which OX40 is lacking 
show a similar defect in CD4 T cell recall responses (93, 102). 
Interestingly, Ag-experienced T cells rapidly respond to IL-7 ex 
vivo to upregulate expression of OX40, a process that does not 
occur in naïve CD4 T cells (93), suggesting that priming of the 
OX40 locus is maintained in these cells. The accumulated evi-
dence from OX40-deficient humans and mice would suggest that 
in, for example, an activated lymph node where Ag-presenting 
cells were induced to express OX40-ligand (TNFSF4), engage-
ment of OX40 on IL-7-stimulated memory CD4 T cells would 
facilitate rapid responses to Ag re-exposure to produce effector 
cytokines (Figure 8A).
Taken together, these observations raise the additional prospect 
that various alternative signaling pathways, which are required for 
the survival of memory T cells, could be involved in maintaining 
the pDHSs in the absence of TCR activation (Figure 8B). Once 
pDHSs have been created in response to AP-1 via TCR signaling, 
these same sites may be reinforced by intermittent recruitment 
of AP-1 and/or STAT family proteins, or other inducible fac-
tors which are activated by IL-7 or TNFRSF signals (103–107) 
(Figure 8B). Indeed, motif analyses showed that STAT and AP-1 
sites are enriched within the pDHSs (Figure 3D) and footprint-
ing data suggests that some of the STAT sites are bound in the 
memory T cells (10). Furthermore, this view is supported by the 
in vitro experiments using the actively dividing T blast cells cul-
tured with IL-2 which also have STAT and AP-1 sites footprinted 
in the pDHSs (10). Since these cells were constantly exposed to 
the gamma chain cytokine IL-2, which is closely related to IL-7, 
it seems that the activation of STAT5 and induction of AP-1 
downstream of these signals may be a common mechanism to 
maintain the pDHSs in an open conformation in both the actively 
proliferating T blast cells and the quiescent memory T cells.
Another intriguing possibility is that STAT5 is acting as a 
molecular “bookmark” which is later replaced by STAT4, STAT6, 
or STAT3 when the cells are exposed to changes in signals 
and polarized to either Th1, Th2, or Th17 cells. An alternative, 
AB
FiGURe 8 | The role of receptor signaling in immunological memory. (A) Long-term immunological memory in CD4 T cells is dependent on cytokine and 
TNFSF networks involving interleukin 7 (IL-7) and OX40 that maintain the rapid recall response in CD4 memory T cells. Stroma-derived IL-7 upregulates expression 
of OX40, the receptor for OX40L, which is produced by antigen-presenting cells. (B) Multiple signaling pathways are predicted to reinforce epigenetic priming in 
memory T cells. T cell receptor (TCR) signaling activates both NFAT and AP-1 that cooperate to transiently induce DNase I hypersensitive sites (DHSs) at enhancers 
and trigger the establishment of primed DHSs. Once priming is established, cytokine and TNFSF signaling pathways can subsequently induce AP-1 and/or STAT 
family transcription factors (but not NFAT) which are predicted to reinforce the priming that was initially introduced via TCR signaling.
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although not mutually exclusive, hypothesis is that STAT5 could 
be working as a transcriptional repressor. Studies in B cells have 
shown that STAT5 binding is associated with the prevention of 
immunoglobulin kappa light chain recombination via a block 
in E2A binding and also through recruitment of the histone 
methyltransferase EZH2 (108, 109). STAT5 could, therefore, be 
interacting with the pDHSs to suppress gene expression while 
maintaining a primed conformation for when the cells are 
re-activated.
CONCLUDiNG STATeMeNT
Taken together, these studies suggest a model whereby immu-
nological memory is maintained by epigenetic reprogramming 
which is first established via TCR signaling, then maintained 
by growth factors such as IL-2 and IL-7 during a prolifera-
tive response in activated T cells, and finally maintained by a 
cytokine network linked to TNFRSF signaling molecules in 
quiescent memory T cells (Figure 9). The key to this model is 
that tight regulation observed at many immune response genes 
is mediated largely at the level of chromatin accessibility, and 
acquired immunity is likely to require regular reinforcement 
of the mechanisms that maintain accessibility. Importantly, the 
epigenetic priming that underpins acquired immunity in T cells 
is maintained by a specific class of regulatory elements, distinct 
from conventional transcriptional enhancers, that function 
primarily to maintain active chromatin rather than directly 
activating transcription.
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FiGURe 9 | Hypothetical model of a gene locus which is stably primed in memory T cells. In this model, T cell receptor (TCR) signaling initially establishes 
priming at primed DHSs (pDHSs) which is regularly reinforced when T cells are exposed to cytokine and/or TNFSF signaling as depicted in Figure 8. Either AP-1 or 
STAT proteins can be recruited to pDHSs. The STAT motifs found in subset of pDHSs are capable of binding STAT proteins linked to multiple cytokine signaling 
pathways, including IL-2, interleukin 7 (IL-7), IL-6, and IL-12, as depicted in Figure 1A.
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